Price Alert

Carl Zeiss Meditec AG (CZMWY)

OTC: CZMWY · Real-Time Price · USD

68.31

1.28 (1.91%)

At close: Jun 06, 2025, 3:58 PM

Carl Zeiss Meditec Balance Sheet Statement

Financials in EUR. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	20.29M	-15.34M	15.34M	-10.6M	10.6M	-12.36M	12.36M	-7.73M	7.73M	-8.4M	8.4M	-7.44M	7.44M	-8.31M	8.31M	-6.2M
Short-Term Investments	n/a	30.68M	18.41M	21.2M	-44.03M	24.73M	31.96M	15.46M	-8.63M	16.8M	13.19M	14.88M	-17.52M	16.63M	9.04M	12.4M
Long-Term Investments	n/a	n/a	13.98M	n/a	65.48M	n/a	-9.55M	n/a	19.45M	n/a	-6.34M	n/a	24.23M	n/a	-4.19M	n/a
Other Long-Term Assets	51.28M	-15.34M	45.18M	-10.6M	963K	-12.36M	76.89M	-7.73M	33.54M	-8.4M	31.14M	-7.44M	785K	-8.31M	24.83M	-6.2M
Receivables	583.18M	n/a	352.21M	n/a	1.3B	n/a	387.75M	n/a	1.37B	n/a	320.52M	n/a	1.29B	n/a	1.14B	n/a
Inventory	536.16M	n/a	555.28M	n/a	520.23M	n/a	441.41M	n/a	382.75M	n/a	328.87M	n/a	286.38M	n/a	274.08M	n/a
Other Current Assets	67.85M	n/a	855.81M	n/a	959.45M	n/a	847.58M	n/a	987.1M	n/a	1.02B	n/a	978.13M	n/a	861.79M	n/a
Total Current Assets	1.21B	15.34M	1.78B	10.6M	1.91B	12.36M	1.69B	7.73M	1.79B	8.4M	1.67B	7.44M	1.6B	8.31M	1.45B	6.2M
Property-Plant & Equipment	353.76M	n/a	332.58M	n/a	315.77M	n/a	283.03M	n/a	236.15M	n/a	205.7M	n/a	199.56M	n/a	189.3M	n/a
Goodwill & Intangibles	1.69B	n/a	684.46M	n/a	675.27M	n/a	631.73M	n/a	670.08M	n/a	543.42M	n/a	482.41M	n/a	467.39M	n/a
Total Long-Term Assets	2.18B	-15.34M	1.14B	-10.6M	1.12B	-12.36M	1.04B	-7.73M	1.03B	-8.4M	851.43M	-7.44M	791.95M	-8.31M	765.96M	-6.2M
Total Assets	3.39B	n/a	2.92B	n/a	3.03B	n/a	2.73B	n/a	2.82B	n/a	2.53B	n/a	2.4B	n/a	2.22B	n/a
Account Payables	183.54M	n/a	186.68M	n/a	239.79M	n/a	192.46M	n/a	189.19M	n/a	140.47M	n/a	145.47M	n/a	123.34M	n/a
Deferred Revenue	n/a	n/a	122.87M	n/a	294.47M	n/a	n/a	n/a	39.91M	n/a	n/a	n/a	280.43M	n/a	169.13M	n/a
Short-Term Debt	n/a	n/a	-122.87M	n/a	n/a	n/a	n/a	n/a	-39.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	263.32M	n/a	59.95M	n/a	193.52M	n/a	165.17M	n/a	193.15M	n/a	230.54M	n/a	190.24M	n/a	114.35M	n/a
Total Current Liabilities	568.84M	n/a	507.44M	n/a	561.65M	n/a	493.17M	n/a	539.32M	n/a	499.26M	n/a	448.12M	n/a	347.87M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	502.65M	-2.11B	53.93M	n/a	52.85M	n/a	126.36M	n/a	147.09M	n/a	169.58M	n/a	121.1M	n/a	182.3M	n/a
Total Long-Term Liabilities	767.89M	-2.11B	305.47M	n/a	298.38M	n/a	260.89M	n/a	253.41M	n/a	270.66M	n/a	270.47M	n/a	306.58M	n/a
Total Liabilities	1.34B	-2.11B	812.91M	n/a	860.02M	n/a	754.06M	n/a	792.73M	n/a	769.92M	n/a	718.59M	n/a	654.45M	n/a
Total Debt	151.35M	n/a	142.01M	n/a	155.7M	n/a	211.3M	n/a	127.9M	n/a	120.05M	n/a	121.27M	n/a	119.9M	n/a
Common Stock	89.44M	n/a	89.44M	n/a	89.44M	n/a	89.44M	n/a	89.44M	n/a	89.44M	n/a	89.44M	n/a	89.44M	n/a
Retained Earnings	1.49B	n/a	1.39B	n/a	1.41B	n/a	1.23B	n/a	1.21B	n/a	1.05B	n/a	1B	n/a	909.53M	n/a
Comprehensive Income	n/a	2.09B	13.35M	2.16B	43.97M	1.96B	24.43M	2.02B	91.63M	1.74B	-20.83M	1.66B	-50.73M	1.55B	-73.56M	1.43B
Shareholders Equity	2.04B	2.11B	2.09B	2.17B	2.16B	1.98B	1.96B	2.03B	2.02B	1.76B	1.74B	1.68B	1.66B	1.56B	1.55B	1.45B
Total Investments	20.38M	30.68M	13.98M	21.2M	21.45M	24.73M	22.42M	15.46M	10.83M	16.8M	6.84M	14.88M	6.71M	16.63M	4.84M	12.4M